1. 4CPS-107 An estimate of avoided costs for drugs in patients included in non-small lung cancer clinical trials. (2nd March 2018) Authors: Alamo, AM; Mateos, E; Nucete, B; Lujan, ME; Lombardero, M; Otero, C Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4CPS-109 Experience of regorafenib use in metastatic colorectal cancer. (2nd March 2018) Authors: Mateos, E; Alamo, AM; Vaswani, A Ramchandani; Pin, M Lombardero; López, ME Luján; García, JA Rodriguez; Villalustre, C Otero; Vera, D Fernandez Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 5PSQ-049 Atezolizumab: efficacy and safety in advanced non-small cell lung cancer. (March 2019) Authors: Fernandez, D; Otero, C; Álamo, A; Mateos, E; Lombardero, M; Lujan, ME; Dorta, D; Dominguez, A Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗